Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.70 |
| ▸ | MAOA | P21397 | 1/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | BCHE | P06276 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | MPO | P05164 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21591483 | 0.93 | ALDH1A1 (0.57) | SIGMAR1MAOACHRM2BCHEALDH1A1 | |
| SCHEMBL28188921 | 0.89 | GAA (0.74) | SIGMAR1MAOAGAAMAPTBCHE | |
| SCHEMBL4065566 | 0.89 | SIGMAR1 (0.88) | SIGMAR1MAOACHRM2GAAMAPT | |
| SCHEMBL7724204 | 0.87 | SIGMAR1 (0.78) | SIGMAR1 | |
| SCHEMBL11883482 | 0.87 | SIGMAR1 (0.84) | SIGMAR1MAOACHRM2GAAMAPT | |
| Bromide SCHEMBL11691228 | 0.87 | SIGMAR1 (0.84) | SIGMAR1MAOACHRM2GAAMAPT | |
| SCHEMBL10416538 | 0.85 | SIGMAR1 (0.62) | SIGMAR1MAOACHRM2GAAMAPT | |
| SCHEMBL21591441 | 0.85 | CHRM2 (0.66) | SIGMAR1CHRM2ALDH1A1TDP1 | |
| SCHEMBL4072845 | 0.83 | CHRM2 (0.73) | SIGMAR1CHRM2 | |
| SCHEMBL7456529 | 0.83 | CHRM2 (0.61) | SIGMAR1CHRM2ALDH1A1MPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1415986-B1 | SPIRO ISOBENZOFURANES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | BANYU PHARMA CO LTD (JP) | 2009-04-08 | — | — | EP | disclosed |
| US-7205417-B2 | Spiro compounds | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-04-17 | — | — | US | disclosed |
| EP-1200440-A1 | QUINUCLIDINE DERIVATIVES FOR TREATMENT OF NEUROLOGICAL DISORDERS | Vertex Pharmaceuticals Incorporated (US) | 2002-05-02 | — | — | EP | disclosed |
| EP-1196386-A2 | N-SUBSTITUTED GLYCINE DERIVATIVES | Vertex Pharmaceuticals Incorporated (US) | 2002-04-17 | — | — | EP | disclosed |
| EP-1196385-A1 | BETA-AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES | Vertex Pharmaceuticals Incorporated (US) | 2002-04-17 | — | — | EP | disclosed |
| WO-2001002361-A1 | BETA-AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2001002363-A2 | N-SUBSTITUTED GLYCINE DERIVATIVES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2001002405-A1 | QUINUCLIDINE DERIVATIVES FOR TREATMENT OF NEUROLOGICAL DISORDERS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2001-01-11 | — | — | WO | disclosed |